The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study

Clinical and Experimental Nephrology

Volumn 23, Issue 5, 2019, Pages 676-688

  Aydin, Malik ^a,b   Franke, Ingo ^a   Kurylowicz, Lisa ^a   Ganschow, Rainer ^a   Lentze, Michael ^a   Born, Mark ^a   Hagemann, Rebekka ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Childhood nephrotic syndrome; Complication; Outcome; Steroid resistant nephrotic syndrome; Steroid sensitive nephrotic syndrome

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; BONE DENSITY; BONE METABOLISM; CARDIOVASCULAR SYSTEM; CATARACT; CHILD GROWTH; CHILDHOOD; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; CONGENITAL NEPHROTIC SYNDROME; CROSS-SECTIONAL STUDY; DISEASE COURSE; ETHNICITY; FAMILY PLANNING; FEMALE; FERTILITY; FOLLOW UP; GERMANY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; ONSET AGE; OSTEOPOROSIS; PREGNANCY; PROGNOSIS; PROTEINURIA; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STEROID SENSITIVE NEPHROTIC SYNDROME; STEROID THERAPY; BONE; CHILD; COMPLICATION; INFANT; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; BONE AND BONES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FERTILITY; GERMANY; HUMANS; INFANT; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREGNANCY; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85061040914     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-019-01696-8     Document Type: Article

References (50)

1. International Study of Kidney Disease in Children/ISKDC. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr. 1981;98:561–4.
2. Nash MA, Edelmann CM Jr, Bernstein J, Barnett HL. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerulosclerosis. In: Edelmann CM Jr, editor. Pediatric kidney disease. 2nd ed. Boston: Little, Brown; 1992. pp. 1267–90.
3. Hussain N, Zello JA, Vasilevska-Ritovska J, Banh TM, Patel VP, Patel P, et al. The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome. BMC Nephrology. 2013;14:25. 10.1186/1471-2369-14-25.
4. Franke I, Aydin M, Llamas Lopez CE, Kurylowicz L, Ganschow R, et al. The incidence of the nephrotic syndrome in childhood in Germany. Clin Exp Nephrol. 2018;22(1):126–32. 10.1007/s10157-017-1433-6.
5. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13–28.
6. International Study of Kidney Disease in Children/ISKDC. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr. 1982;101:514–8.
7. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769–76.
8. Broyer M, Meyrier A, Niaudet P, Habib R. Minimal changes and focal segmental glomerular sclerosis. In: Davison AM, editor. Oxford textbook of clinical nephrology. 2nd ed. Vol. 1. Oxford: Oxford university Press; 1998. pp. 493–535.
9. Gipson DS, Chin H, Presler TP, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21:344–9.
10. Siegel NJ, Goldberg B, Krassner LS, Hayslett JP. Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr. 1972;81:251–8.
11. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550–7.
12. Rüth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005;147:202–7.
13. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Long-term outcome for children with minimal-change nephrotic syndrome. Lancet. 1985;1:368–70.
14. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome: From toddlers to twenties. Lancet. 1989;1:255–9.
15. Schwartz MW, Schwartz GJ, Cornfeld D. A 16 year follow up study of 163 children with nephrotic syndrome. Pediatrics. 1974;54:548–52.
16. Zidar N, Cavic MA, Kenda RB, Ferluga D. Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation. Kidney Int. 1998;54:1320–3.
17. Sheu JN, Jeun-Horng C. Minimal Change Nephrotic Syndrome in Children with Intrauterine Growth Retardation. Am J Kidney Dis. 2001;37:909–14.
18. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990;301:259–62.
19. Barker DJP, Winter PD, Osmond C, Simmons SJ. Weight in infancy and death from ischemic heart disease. Lancet. 1989;2:577–80.
20. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019–22.
21. Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol. 1992;99:296–301.
22. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113–22.
23. Manalich R, Reyes L, Herrera M, Melendi C, Fundora I. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 2000;58:770–3.
24. Matsukura H, Inaba S, Shinozaki K, Yanagihara T, Hara M, Higuchi A, Takada T, Tanizawa T, Miyawaki T. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome. Am J Nephrol. 2001;21:362–7.
25. Motoyama O, Iitaka K. Final height in children with steroid-sensitive nephrotic syndrome. Pediatrics Int. 2007;49:623–5.
26. Koskimies O, Vilska J, Rapola J, Hallmann N. Long-term outcome of primary nephrotic syndrome. Arch Dis Child. 1982;57:544–8.
27. Calderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, et al. History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med. 2018;378(5):428–38.
28. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid sensitive nephrotic syndrome. N Engl J Med. 2004;351:868–75.
29. Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol. 2005;20:56–63.
30. Truthmann J, Mensink GBM, Bosy-Westphal A, Scheidt-Nave C, Schienkiewitz A. Metabolic Health in Relation to Body Size: Changes in Prevalence over Time between 1997-99 and 2008-11 in Germany. PLoS One. 2016;11(11):e0167159.
31. Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14(1):57–70. 10.1038/nrneph.2017.155.
32. Elmaoğulları S, Tepe D, Uçaktürk SA, Karaca Kara F, Demirel F. Prevalence of dyslipidemia and associated factors in obese children and adolescents. J Clin Res Pediatr Endocrinol. 2015;7(3):228–34.
33. Korsten-Reck U, Kromeyer-Hauschild K, Korsten K, Baumstark MW, Dickhuth HH, Berg A. Frequency of secondary dyslipidemia in obese children. Vasc Health Risk Manag. 2008;4(5):1089–94.
34. Mérouani A, Lévy E, Mongeau J-J, Robitaille P, Lambert M, Delvin EE. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem. 2003;36:571–4.
35. Kniazewska MH, Obuchowics AK, Wielkoszyński T, Zmudzińska-Kitczak J, Urban K, Marek M, Witanowska J, Sieroń-Stołtny K. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2009;24:549–54.
36. Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid responsive nephrotic syndrome. Pediatr Nephrol. 2003;18:783–8.
37. Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid responsive nephrotic syndrome. Lancet. 1985;2:917–9.
38. Foster BJ, Shults J, Zemel BS, Leonard MB. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2006;21:973–80.
39. Salsano ME, Graziano L, Luongo I, Pilla P, Giordano M, Lama G. Atopy in childhood idiopathic nephrotic syndrome. Acta paediatrica. 2007;96:561–6.
40. Meadow SR, Sarsfield JK, Scott DG, Rajah SM. Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child. 1981;56:517–24.
41. Hu JF, Liu YZ. Elevated serum IgE levels in children with nephrotic syndrome, a steroid-resistant sign? Nephron. 1990;54:275.
42. Abdel-Havez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic nephrotic syndrome and atopy. Is there a common link? Am J Kidney Dis. 2009;54(5):945–53.
43. Mundy K, Nichols E, Lindsey J. Socioeconomic disparities in cataract prevalence, characteristics, and management. Semin Ophthalmol. 2016;31(4):358–63.
44. Brocklebank JT, Harcourt RB, Meadow SR. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Childhood. 1982;53:30–4.
45. Bogdanovic R, Banicevic M, Cvoric A. Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study. Pediatr Nephrol. 1990;4:451–4.
46. Callis L, Nieto J, Vila A, Rende J. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr. 1980;97:653–6.
47. Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr. 1978;92:299–303.
48. Penso J, Lippe B, Ehrlich R, Smith FG. Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr. 1974;84:831–6.
49. Rapola J, Koskimies O, Huttunen NP, Floman P, Vilska J, Hallmann N. Cyclophoshamide and the pubertal testis. Lancet. 1973;1:98–9.
50. Basu B, Babu BG, Mahapatra TK. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic syndrome. Clin Exp Nephrol. 2017;21(1):143–51.